Castle Biosciences (CSTL) EBT Margin Growth (1y) (2019 - 2026)
Castle Biosciences (CSTL) EBT Margin Growth (1y) (2019 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 31,055.11 Bn | 31,054.65 Bn | 1.11 Bn | -2,855.00 |
| 2 | Thermo Fisher Scientific | 191.02 Bn | 187.77 Bn | 7.74 Bn | 13.00 |
| 3 | Danaher | 137.16 Bn | 131.47 Bn | 3.59 Bn | 109.00 |
| 4 | Idexx Laboratories | 42.82 Bn | 42.62 Bn | 722.74 Mn | 10.00 |
| 5 | Natera | 39.09 Bn | 37.99 Bn | 696.04 Mn | 113.00 |
| 6 | Agilent Technologies | 37.61 Bn | 35.81 Bn | 990.00 Mn | 665.00 |
| 7 | Iqvia Holdings | 34.23 Bn | 32.25 Bn | 1.36 Bn | -53.00 |
| 8 | Illumina | 28.14 Bn | 26.98 Bn | 721.00 Mn | -309.00 |
| 9 | Mettler Toledo International | 26.40 Bn | 26.33 Bn | 555.82 Mn | -71.00 |
| 10 | Castle Biosciences | 738.56 Mn | 476.84 Mn | 63.15 Mn | 1,263.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1,263.00 |
| Dec 31, 2025 | -1,225.00 |
| Sep 30, 2025 | -1,012.00 |
| Jun 30, 2025 | -923.00 |
| Mar 31, 2025 | -2,645.00 |
| Dec 31, 2024 | 1,298.00 |
| Sep 30, 2024 | 2,083.00 |
| Jun 30, 2024 | 4,648.00 |
| Mar 31, 2024 | 6,603.00 |
| Dec 31, 2023 | 4,979.00 |
| Sep 30, 2023 | 4,353.00 |
| Jun 30, 2023 | -2,707.00 |
| Mar 31, 2023 | 2,176.00 |
| Dec 31, 2022 | 689.00 |
| Sep 30, 2022 | -448.00 |
| Jun 30, 2022 | 2,826.00 |
| Mar 31, 2022 | -7,244.00 |
| Dec 31, 2021 | -3,275.00 |
| Sep 30, 2021 | -2,007.00 |
| Jun 30, 2021 | -2,778.00 |